Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 16 | 47 | 32 | 3 | 3 | 93 |
Lung neoplasms | D008175 | — | C34.90 | 13 | 41 | 20 | 2 | 2 | 72 |
Biliary tract neoplasms | D001661 | — | C24.9 | 18 | 44 | 13 | 1 | 3 | 66 |
Neoplasms | D009369 | — | C80 | 29 | 18 | 2 | 1 | — | 40 |
Nasopharyngeal carcinoma | D000077274 | — | — | 3 | 12 | 11 | 1 | — | 25 |
Nasopharyngeal neoplasms | D009303 | — | — | 3 | 11 | 10 | 1 | — | 23 |
Recurrence | D012008 | — | — | 2 | 4 | 8 | 1 | 1 | 15 |
Lymphoma | D008223 | — | C85.9 | 2 | 7 | 2 | 1 | 2 | 13 |
T-cell lymphoma | D016399 | — | — | — | 2 | 1 | 1 | 2 | 6 |
T-cell lymphoma peripheral | D016411 | — | — | — | 2 | 1 | 1 | 1 | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Carcinoma | D002277 | — | C80.0 | 13 | 36 | 22 | — | 2 | 68 |
Cholangiocarcinoma | D018281 | — | C22.1 | 16 | 35 | 11 | — | 6 | 61 |
Urinary bladder neoplasms | D001749 | — | C67 | 10 | 33 | 14 | — | 4 | 55 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 14 | 31 | 4 | — | — | 40 |
Transitional cell carcinoma | D002295 | — | — | 6 | 14 | 8 | — | 2 | 28 |
Adenocarcinoma | D000230 | — | — | 9 | 15 | 4 | — | 1 | 24 |
Gallbladder neoplasms | D005706 | EFO_0004606 | C23 | 6 | 10 | 3 | — | 2 | 20 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 5 | 14 | 3 | — | — | 18 |
Urologic neoplasms | D014571 | — | C64-C68 | 4 | 7 | 5 | — | 1 | 14 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 6 | 5 | 3 | — | — | 12 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Stomach neoplasms | D013274 | EFO_0003897 | C16 | 4 | 3 | — | — | — | 6 |
Endometrial neoplasms | D016889 | EFO_0004230 | — | 3 | 4 | — | — | — | 5 |
Ductal carcinoma | D044584 | — | — | 2 | 3 | — | — | — | 5 |
Esophageal neoplasms | D004938 | — | C15 | 2 | 2 | — | — | — | 4 |
Malignant mesothelioma | D000086002 | — | — | 3 | 1 | — | — | — | 4 |
Mesothelioma | D008654 | — | C45 | 3 | 1 | — | — | — | 4 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 3 | 1 | — | — | — | 4 |
Invasive hydatidiform mole | D002820 | — | D39.2 | 1 | 2 | — | — | — | 3 |
Colorectal neoplasms | D015179 | — | — | 3 | 2 | — | — | — | 3 |
B-cell lymphoma | D016393 | — | — | 2 | 2 | — | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Melanoma | D008545 | — | — | 1 | — | — | — | — | 1 |
Colonic neoplasms | D003110 | — | C18 | 1 | — | — | — | — | 1 |
Syndrome | D013577 | — | — | 1 | — | — | — | — | 1 |
Small cell carcinoma | D018288 | — | — | 1 | — | — | — | — | 1 |
Penile neoplasms | D010412 | — | C60 | 1 | — | — | — | — | 1 |
Second primary neoplasms | D016609 | — | — | 1 | — | — | — | — | 1 |
Neoadjuvant therapy | D020360 | — | — | 1 | — | — | — | — | 1 |
Immunotherapy | D007167 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prognosis | D011379 | — | — | — | — | — | — | 1 | 1 |
Non-muscle invasive bladder neoplasms | D000093284 | — | — | — | — | — | — | 1 | 1 |
Drug common name | — |
INN | — |
Description | — |
Classification | Unknown |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | — |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | — |